Cann Group Ltd (CAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.000x

Based on the latest financial reports, Cann Group Ltd (CAN) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.00K ≈ $-7.78K USD) by net assets (AU$34.16 Million ≈ $24.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Cann Group Ltd to measure how much of total assets are equity-financed.

Cann Group Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Cann Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Cann Group Ltd to evaluate the quality of earnings relative to operating cash generation.

Cann Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cann Group Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Property Franchise Group PLC
LSE:TPFG
0.089x
Pool Safe Inc
V:POOL
-3.557x
Akg Exim Limited
NSE:AKG
0.050x
FW Thorpe PLC
LSE:TFW
0.081x
Impera Capital S.A.
WAR:IMP
-0.010x
Bioter S.A.
AT:BIOT
0.009x
Odd Burger Corp
V:ODD
0.012x
Empire Metals Limited
LSE:EEE
-0.267x

Annual Cash Flow Conversion Efficiency for Cann Group Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Cann Group Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-2.77 Million
≈ $-1.96 Million
AU$-9.64 Million
≈ $-6.82 Million
3.475x +418.57%
2024-06-30 AU$13.92 Million
≈ $9.85 Million
AU$-15.19 Million
≈ $-10.74 Million
-1.091x -183.08%
2023-06-30 AU$59.26 Million
≈ $41.93 Million
AU$-22.84 Million
≈ $-16.16 Million
-0.385x -60.11%
2022-06-30 AU$84.90 Million
≈ $60.07 Million
AU$-20.43 Million
≈ $-14.46 Million
-0.241x -6.15%
2021-06-30 AU$91.87 Million
≈ $65.01 Million
AU$-20.83 Million
≈ $-14.74 Million
-0.227x +21.40%
2020-06-30 AU$61.07 Million
≈ $43.21 Million
AU$-17.62 Million
≈ $-12.47 Million
-0.288x -200.42%
2019-06-30 AU$77.30 Million
≈ $54.69 Million
AU$-7.42 Million
≈ $-5.25 Million
-0.096x -119.63%
2018-06-30 AU$85.87 Million
≈ $60.76 Million
AU$-3.75 Million
≈ $-2.66 Million
-0.044x +72.12%
2017-06-30 AU$14.66 Million
≈ $10.37 Million
AU$-2.30 Million
≈ $-1.63 Million
-0.157x +78.75%
2016-06-30 AU$1.69 Million
≈ $1.20 Million
AU$-1.25 Million
≈ $-882.14K
-0.738x +25.57%
2015-06-30 AU$648.33K
≈ $458.73K
AU$-642.74K
≈ $-454.78K
-0.991x --

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$3.45 Million
AU$4.88 Million AUD
Market Cap Rank
#29200 Global
#1625 in Australia
Share Price
AU$0.00
Change (1 day)
+20.00%
52-Week Range
AU$0.00 - AU$0.02
All Time High
AU$3.98
About

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.